SE9803239D0 - Composition for the treatment of acute pain - Google Patents

Composition for the treatment of acute pain

Info

Publication number
SE9803239D0
SE9803239D0 SE9803239A SE9803239A SE9803239D0 SE 9803239 D0 SE9803239 D0 SE 9803239D0 SE 9803239 A SE9803239 A SE 9803239A SE 9803239 A SE9803239 A SE 9803239A SE 9803239 D0 SE9803239 D0 SE 9803239D0
Authority
SE
Sweden
Prior art keywords
composition
treatment
acute pain
fentanyl
essentially water
Prior art date
Application number
SE9803239A
Other languages
English (en)
Swedish (sv)
Inventor
Crister Nystroem
Anders Pettersson
Thomas Hedner
Hans Lennernaes
Bo Lennernaes
Original Assignee
Diabact Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20412701&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9803239(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Diabact Ab filed Critical Diabact Ab
Priority to SE9803239A priority Critical patent/SE9803239D0/xx
Publication of SE9803239D0 publication Critical patent/SE9803239D0/xx
Priority to NZ510646A priority patent/NZ510646A/en
Priority to CA002345064A priority patent/CA2345064C/fr
Priority to EP99952868A priority patent/EP1115384B1/fr
Priority to AU64928/99A priority patent/AU764473B2/en
Priority to PL347467A priority patent/PL197078B1/pl
Priority to JP2000573712A priority patent/JP2002526440A/ja
Priority to BRPI9913948-0A priority patent/BR9913948B1/pt
Priority to IL14212699A priority patent/IL142126A0/xx
Priority to PT99952868T priority patent/PT1115384E/pt
Priority to EEP200100176A priority patent/EE200100176A/xx
Priority to US09/787,887 priority patent/US6759059B1/en
Priority to HU1300339A priority patent/HU230688B1/hu
Priority to PCT/SE1999/001688 priority patent/WO2000016751A1/fr
Priority to KR1020017003714A priority patent/KR100760531B1/ko
Priority to HU0103621A priority patent/HU228992B1/hu
Priority to SK401-2001A priority patent/SK283503B6/sk
Priority to AT99952868T priority patent/ATE247950T1/de
Priority to RU2001111026/15A priority patent/RU2232580C2/ru
Priority to ES99952868T priority patent/ES2207295T3/es
Priority to DK99952868T priority patent/DK1115384T3/da
Priority to CNB998136220A priority patent/CN1170524C/zh
Priority to CZ20011030A priority patent/CZ301562B6/cs
Priority to DE69910803T priority patent/DE69910803T2/de
Priority to TR2001/00812T priority patent/TR200100812T2/xx
Priority to IL142126A priority patent/IL142126A/en
Priority to NO20011502A priority patent/NO332228B1/no
Priority to BG105380A priority patent/BG65363B1/bg
Priority to JP2004167572A priority patent/JP4478512B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9803239A 1998-09-24 1998-09-24 Composition for the treatment of acute pain SE9803239D0 (sv)

Priority Applications (29)

Application Number Priority Date Filing Date Title
SE9803239A SE9803239D0 (sv) 1998-09-24 1998-09-24 Composition for the treatment of acute pain
DE69910803T DE69910803T2 (de) 1998-09-24 1999-09-24 Fentanylzusammensetzung zur behandlung von akutem schmerz
TR2001/00812T TR200100812T2 (tr) 1998-09-24 1999-09-24 Akut ağrı tedavisi için fentanil kompozisyon.
PCT/SE1999/001688 WO2000016751A1 (fr) 1998-09-24 1999-09-24 Composition de fentanyl pour le traitement des douleurs aigues
KR1020017003714A KR100760531B1 (ko) 1998-09-24 1999-09-24 급성 통증 치료용 펜타닐 조성물
EP99952868A EP1115384B1 (fr) 1998-09-24 1999-09-24 Composition de fentanyl pour le traitement des douleurs aigues
AU64928/99A AU764473B2 (en) 1998-09-24 1999-09-24 Fentanyl composition for the treatment of acute pain
PL347467A PL197078B1 (pl) 1998-09-24 1999-09-24 Kompozycja farmaceutyczna do podawania podjęzykowego do leczenia ostrego bólu oraz zastosowania
JP2000573712A JP2002526440A (ja) 1998-09-24 1999-09-24 急性疼痛の処置のためのフェンタニル組成物
BRPI9913948-0A BR9913948B1 (pt) 1998-09-24 1999-09-24 composição farmacêutica para o tratamento de dor aguda por administração sublingual, uso de fentanila ou um sal farmaceuticamente aceitável da mesma, e, uso de uma composição farmacêutica essencialmente isenta de água.
IL14212699A IL142126A0 (en) 1998-09-24 1999-09-24 Fentanyl composition for the treatment of acute pain
PT99952868T PT1115384E (pt) 1998-09-24 1999-09-24 Composicao de fentamil para o tratamento de dor aguda
EEP200100176A EE200100176A (et) 1998-09-24 1999-09-24 Fentanüüli kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette nähtud akuutse valu raviks, ning farmatseutiline kompositsioon
US09/787,887 US6759059B1 (en) 1998-09-24 1999-09-24 Fentanyl composition for the treatment of acute pain
HU1300339A HU230688B1 (hu) 1998-09-24 1999-09-24 Fentanil készítmény akut fájdalom kezelésére
NZ510646A NZ510646A (en) 1998-09-24 1999-09-24 A sublingual composition comprising fentanyl adhered to microparticles for the treatment of acute pain
CA002345064A CA2345064C (fr) 1998-09-24 1999-09-24 Composition de fentanyl pour le traitement des douleurs aigues
HU0103621A HU228992B1 (en) 1998-09-24 1999-09-24 Sublingual fentanyl composition for the treatment of acute pain
SK401-2001A SK283503B6 (sk) 1998-09-24 1999-09-24 Farmaceutický prostriedok na liečbu akútnej bolesti
AT99952868T ATE247950T1 (de) 1998-09-24 1999-09-24 Fentanylzusammensetzung zur behandlung von akutem schmerz
RU2001111026/15A RU2232580C2 (ru) 1998-09-24 1999-09-24 Композиция фентанила для лечения острой боли
ES99952868T ES2207295T3 (es) 1998-09-24 1999-09-24 Composicion de fentanil para el tratamiento de dolor agudo.
DK99952868T DK1115384T3 (da) 1998-09-24 1999-09-24 Fentanyl-præparat til behandling af akutte smerter
CNB998136220A CN1170524C (zh) 1998-09-24 1999-09-24 用于治疗急性疼痛的芬太尼化合物
CZ20011030A CZ301562B6 (cs) 1998-09-24 1999-09-24 Farmaceutický prostredek pro lécení akutní bolesti a použití fentanylu pro jeho prípravu
IL142126A IL142126A (en) 1998-09-24 2001-03-20 Fentanyl preparation for the treatment of pain
BG105380A BG65363B1 (bg) 1998-09-24 2001-03-23 Фармацевтичен състав, съдържащ фентанил, за облекчаване на остра болка
NO20011502A NO332228B1 (no) 1998-09-24 2001-03-23 Farmasoytisk sammensetning inneholdende fentanyl for behandling av akutt smerte, samt anvendelse av fentanyl for fremstilling av en farmasoytisk sammensetning.
JP2004167572A JP4478512B2 (ja) 1998-09-24 2004-06-04 急性疼痛の処置のためのフェンタニル組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803239A SE9803239D0 (sv) 1998-09-24 1998-09-24 Composition for the treatment of acute pain

Publications (1)

Publication Number Publication Date
SE9803239D0 true SE9803239D0 (sv) 1998-09-24

Family

ID=20412701

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803239A SE9803239D0 (sv) 1998-09-24 1998-09-24 Composition for the treatment of acute pain

Country Status (26)

Country Link
US (1) US6759059B1 (fr)
EP (1) EP1115384B1 (fr)
JP (2) JP2002526440A (fr)
KR (1) KR100760531B1 (fr)
CN (1) CN1170524C (fr)
AT (1) ATE247950T1 (fr)
AU (1) AU764473B2 (fr)
BG (1) BG65363B1 (fr)
BR (1) BR9913948B1 (fr)
CA (1) CA2345064C (fr)
CZ (1) CZ301562B6 (fr)
DE (1) DE69910803T2 (fr)
DK (1) DK1115384T3 (fr)
EE (1) EE200100176A (fr)
ES (1) ES2207295T3 (fr)
HU (2) HU228992B1 (fr)
IL (2) IL142126A0 (fr)
NO (1) NO332228B1 (fr)
NZ (1) NZ510646A (fr)
PL (1) PL197078B1 (fr)
PT (1) PT1115384E (fr)
RU (1) RU2232580C2 (fr)
SE (1) SE9803239D0 (fr)
SK (1) SK283503B6 (fr)
TR (1) TR200100812T2 (fr)
WO (1) WO2000016751A1 (fr)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
MXPA02004293A (es) 1999-10-29 2002-10-31 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada..
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
IT1318618B1 (it) * 2000-07-10 2003-08-27 A C R Applied Coating Res S A Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
US8017627B2 (en) 2000-07-31 2011-09-13 Nycomed Danmark Aps Fentanyl composition for nasal administration
CN100518827C (zh) 2000-10-30 2009-07-29 欧罗赛铁克股份有限公司 控释氢可酮制剂
WO2003002071A2 (fr) * 2001-06-29 2003-01-09 Lewandowski Leon J Therapie de sevrage individualisee en cas de dependance
FR2827517B1 (fr) 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
US7109310B2 (en) * 2001-11-16 2006-09-19 Randox Laboratories, Ltd. Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
CN100581586C (zh) * 2003-01-31 2010-01-20 奥雷克索公司 一种快速起效的药物组合物
KR20050115276A (ko) * 2003-03-11 2005-12-07 아라키스 리미티드 신규한 조성물
JP5137286B2 (ja) 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
KR101184138B1 (ko) 2003-12-31 2012-09-19 시마 랩스 인크. 일반적인 선형 발포성 경구 펜타닐 투약 제형 및 투여 방법
JP5244318B2 (ja) * 2003-12-31 2013-07-24 シーマ・ラブス、インコーポレイテッド 発泡性経口アヘン薬投薬形態およびアヘン薬の投与方法
US7858121B2 (en) * 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
US7658945B2 (en) * 2004-02-17 2010-02-09 Transcept Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
GB0423800D0 (en) * 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
EP1863456A1 (fr) * 2005-03-28 2007-12-12 Orexo AB Nouvelles compositions pharmaceutiques utiles dans le traitement de la douleur
AU2006249761A1 (en) * 2005-05-25 2006-11-30 Transcept Pharmaceuticals, Inc. Solid compositions and methods for treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
EP1968539A2 (fr) * 2005-12-13 2008-09-17 Biodelivery Sciences International, Inc. Dispositif resistant aux abus pour l'administration transmucosale de medicaments
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
CN101394863B (zh) * 2006-01-06 2016-12-21 阿塞尔Rx制药有限公司 小体积口腔经粘膜剂型
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US9066847B2 (en) * 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8252329B2 (en) * 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
BRPI0707235B8 (pt) * 2006-01-25 2021-05-25 Insys Therapeutics Inc formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual
EP1837020A1 (fr) 2006-03-24 2007-09-26 Bioalliance Pharma Vehicule bioadhesif pour les muqueuses pour delivrer lentement des principes actifs
US20070260491A1 (en) * 2006-05-08 2007-11-08 Pamela Palmer System for delivery and monitoring of administration of controlled substances
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20080069891A1 (en) * 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
EP3067044B1 (fr) 2006-07-21 2019-03-27 BioDelivery Sciences International, Inc. Dispositifs d'administration transmuqueuse avec absorption accrue
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US20080090874A1 (en) * 2006-09-20 2008-04-17 Messina John C Jr Treatment of breakthrough pain in patients suffering from chronic low back pain
FR2907680B1 (fr) * 2006-10-27 2012-12-28 Scras Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux
US8470361B2 (en) * 2006-12-04 2013-06-25 Orexo Ab Non-abusable pharmaceutical composition comprising opioids
CA2677281C (fr) * 2007-02-09 2019-10-29 Durect Corporation Formes posologiques par voie orale comprenant du sufentanile et de la naloxone
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US20080287494A1 (en) * 2007-04-24 2008-11-20 Cephalon, Inc. Transmucosal treatment methods in patients with mucositis
CN101686931B (zh) * 2007-06-06 2013-06-19 巴斯夫欧洲公司 用于制备可咀嚼片剂和锭剂的药物配制剂
NO2180844T3 (fr) 2007-08-02 2018-07-21
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
EP2295046B1 (fr) * 2009-09-14 2012-12-19 Acino AG Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
EP3064064A1 (fr) 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Procédés et compositions de dissuasion d'abus
MY150626A (en) 2009-10-30 2014-02-07 Ix Biopharma Ltd Fast dissolving solid dosage form
US8927025B2 (en) 2010-05-11 2015-01-06 Cima Labs Inc. Alcohol-resistant metoprolol-containing extended-release oral dosage forms
US20120183580A1 (en) * 2011-01-13 2012-07-19 Theralpha Analgesic Composition for Transbuccal Administration
AU2012296346A1 (en) 2011-08-18 2014-04-03 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
AU2012311293B2 (en) 2011-09-19 2014-02-20 Orexo Ab New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
DE102012006396A1 (de) 2012-03-29 2013-10-02 Willy Rüsch GmbH Tracheostomietubus
PE20142444A1 (es) 2012-05-02 2015-01-09 Orexo Ab Nueva composicion de alfentanilo para el tratamiento del dolor agudo
CN107595793B (zh) 2012-11-30 2020-11-13 阿库拉制药公司 活性药物成分的自调节释放
WO2015065547A1 (fr) 2013-10-31 2015-05-07 Cima Labs Inc. Formes pharmaceutiques en granulés anti-abus à libération immédiate
WO2015119641A1 (fr) * 2014-02-07 2015-08-13 Scilabs Pharmaceuticals Systèmes d'administration sublinguale de médicaments non toxiques, entièrement naturels
WO2016086095A1 (fr) 2014-11-25 2016-06-02 Biodelivery Sciences International, Inc. Timbres, procédés de formation et de test de timbres d'administration d'agent pharmaceutique
WO2017040607A1 (fr) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Procédés et compositions pour la libération auto-régulée d'un ingrédient pharmaceutique actif
US20220062200A1 (en) 2019-05-07 2022-03-03 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
WO2020225773A1 (fr) 2019-05-07 2020-11-12 Clexio Biosciences Ltd. Formes posologiques dissuasives d'abus contenant de l'eskétamine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
SE8800080L (sv) * 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
JP3836566B2 (ja) * 1996-05-13 2006-10-25 久光製薬株式会社 フェンタニル含有経皮投与テープ製剤
JP3943724B2 (ja) * 1998-07-31 2007-07-11 東光薬品工業株式会社 フェンタニル含有経皮投与マトリックス型貼付剤
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action

Also Published As

Publication number Publication date
PT1115384E (pt) 2004-01-30
NZ510646A (en) 2004-04-30
CZ20011030A3 (cs) 2001-09-12
HU228992B1 (en) 2013-07-29
RU2232580C2 (ru) 2004-07-20
IL142126A0 (en) 2002-03-10
CN1170524C (zh) 2004-10-13
PL347467A1 (en) 2002-04-08
JP4478512B2 (ja) 2010-06-09
ES2207295T3 (es) 2004-05-16
EP1115384B1 (fr) 2003-08-27
JP2004269545A (ja) 2004-09-30
IL142126A (en) 2006-04-10
EE200100176A (et) 2002-08-15
CN1328448A (zh) 2001-12-26
SK283503B6 (sk) 2003-08-05
CA2345064C (fr) 2008-05-27
DK1115384T3 (da) 2003-12-22
DE69910803T2 (de) 2004-06-17
AU6492899A (en) 2000-04-10
CZ301562B6 (cs) 2010-04-14
WO2000016751A1 (fr) 2000-03-30
ATE247950T1 (de) 2003-09-15
SK4012001A3 (en) 2001-10-08
HU230688B1 (hu) 2017-09-28
NO332228B1 (no) 2012-07-30
BG65363B1 (bg) 2008-04-30
PL197078B1 (pl) 2008-02-29
BG105380A (en) 2001-12-29
CA2345064A1 (fr) 2000-03-30
HUP0103621A3 (en) 2005-05-30
HUP0103621A2 (hu) 2002-02-28
KR100760531B1 (ko) 2007-10-04
BR9913948B1 (pt) 2011-02-08
TR200100812T2 (tr) 2001-07-23
DE69910803D1 (de) 2003-10-02
KR20010075314A (ko) 2001-08-09
JP2002526440A (ja) 2002-08-20
NO20011502D0 (no) 2001-03-23
US6759059B1 (en) 2004-07-06
BR9913948A (pt) 2001-06-12
AU764473B2 (en) 2003-08-21
EP1115384A1 (fr) 2001-07-18
NO20011502L (no) 2001-03-23

Similar Documents

Publication Publication Date Title
SE9803239D0 (sv) Composition for the treatment of acute pain
MXPA01003068A (es) Composicion farmaceutica para el tratamiento de alteraciones agudas.
HK1080387A1 (en) A rapid-acing pharmaceutical composition
DE69803360T2 (de) Anwendungsformen zur behandlung der männlichen erektilen dysfunktion